Cutler Group LLC / CA - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 164 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10.0%1,2000.0%0.00%
Q2 2023$10.0%1,2000.0%0.00%
Q1 2023$10.0%1,2000.0%0.00%
Q4 2022$1
-99.9%
1,2000.0%0.00%
Q3 2022$1,0000.0%1,2000.0%0.00%
Q2 2022$1,000
-66.7%
1,200
-52.0%
0.00%
Q1 2022$3,0000.0%2,500
-13.8%
0.00%
Q4 2021$3,000
-25.0%
2,900
-68.1%
0.00%
Q3 2021$4,000
-63.6%
9,100
+106.7%
0.00%
-100.0%
Q2 2021$11,000
+120.0%
4,403
+51.8%
0.00%
Q1 2021$5,000
-85.3%
2,900
-91.8%
0.00%
-100.0%
Q4 2020$34,000
+1600.0%
35,362
+1864.6%
0.00%
Q3 2020$2,000
-77.8%
1,800
-89.2%
0.00%
Q1 2019$9,000
+50.0%
16,700
+70.4%
0.00%
Q4 2018$6,000
-14.3%
9,8000.0%0.00%
Q3 2018$7,000
-61.1%
9,800
+84.9%
0.00%
-100.0%
Q1 2018$18,000
+350.0%
5,300
-61.2%
0.00%
Q4 2016$4,000
-71.4%
13,675
+1.3%
0.00%
-100.0%
Q3 2016$14,00013,500
+6650.0%
0.00%
Q2 2016$02000.0%0.00%
Q1 2016$02000.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
CM Management, LLC 1,500,000$1,620,0001.72%
Soleus Capital Management, L.P. 14,803,015$15,987,2561.48%
ARMISTICE CAPITAL, LLC 17,136,000$18,506,8800.28%
SPHERA FUNDS MANAGEMENT LTD. 1,228,126$1,326,3760.24%
GSA CAPITAL PARTNERS LLP 971,441$1,0490.09%
NJ State Employees Deferred Compensation Plan 200,000$216,0000.03%
Providence Wealth Advisors, LLC 27,500$29,0130.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,151,765$1,243,9060.03%
XTX Topco Ltd 164,238$177,3770.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 3,369,076$3,638,6020.02%
View complete list of RIGEL PHARMACEUTICALS INC shareholders